Exelixis, Inc. (EXEL)
50.13
-0.97
(-1.90%)
USD |
NASDAQ |
May 15, 16:00
50.14
+0.02
(+0.03%)
After-Hours: 20:00
Exelixis Shareholders Equity (Quarterly) : 1.936B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Merck & Co., Inc. | 45.88B |
| Madrigal Pharmaceuticals, Inc. | 543.45M |
| Krystal Biotech, Inc. | 1.277B |
| Arcus Biosciences, Inc. | 524.00M |
| Immunome, Inc. | 588.69M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.594B |
| Total Liabilities (Quarterly) | 657.84M |
| Debt to Equity Ratio | 0.0876 |
| Current Ratio | 3.258 |
| Net Debt Paydown Yield | 0.09% |